Last updated on 03 March 2026

In brief

As every year, CROI will highlight the newest and most consequential research in retroviruses and opportunistic infections.

CROI 2026: Oral presentations of research supported by ANRS MIE

  • Intensification of tuberculosis treatment in severely immunocompromised individuals with HIV by François-Xavier Blanc et al, CHU-Nantes
  • Nucleocapsid mutations during virological failure of an integrase inhibitor-based regimen by Quentin Le Hingrat et al, Université Paris Cité, AP-HP
  • Toward an optimized LAM assays for accurate pediatric tuberculosis diagnosis? by Jean-Pierre Moles et al, université de Montpellier, Inserm
  • Final results of the ANRS Prevenir study with daily or on demand oral prep with TDF/FTC in Paris, France by Jean-Michel Molina, Université Paris Cité, AP-HP

François-Xavier Blanc

ntensification of tuberculosis treatment in severely immunocompromised individuals with HIV

Jean-Victor Blanc

Mental health of MSM on PrEP in ANRS PREVENIR study: a group-based trajectory model

Caroline Charre

Impact of early treatment initiation after perinatal HIV infection on intact provirus levels

Victor Euzen

Anal microbiome dynamics in MSM of the DEPIST-H/ANRS12400 cohort: HSV-Linked Dysbiosis and HR-HPV Persistence

Fatoumata Fadiga

Evolution of weight under dual therapy without tenofovir compared to triple therapy: Week 96 results from the MODERATO Trial (ANRS -MIE 12372)

Pierre Frange

HBV burden and poor vaccine-induced protection in adolescents with HIV-1 in West and Central Africa

Pierre Frange

Low rate of resistance to dolutegravir in adolescents living with HIV-1 in West and Central Africa

Hegger Fritsch

Continuous increase in HIV-1 resistance to neutralization by BNABS over the past 30 years

Nour Gazzhaui

In vitro and in vivo immunogenicity of a dendritic cell-based vaccine targeting HBV epitopes

Jade Ghosn

HPV prevalence at multiple anatomical sites among transgender people: the PREVHPV-TG ANRS Study

Beatriz Grinsztejn

Prediction analysis on lesion resolution in people with Mpox: Results from the UNITY open label arm

Quentin Le Hingrat

Nucleocapsid mutations during virological failure of an integrase inhibitor-based regimen

Alain Makinson

Neurocognitive decline in PWH with virological response versus controls : the ANRS Aging HAND Study

Jean-Pierre Moles

Toward an optimized LAM assays for accurate pediatric tuberculosis diagnosis?

Jean-Michel Molina

Final results of the ANRS prevenir study with daily or on demand oral prep with TDF/FTC in Paris, France

Cathia Soulié

From widespread use to salvage therapy: Seventeen years of protease inhibitor resistance dynamics

Elisa Teyssou

In addition to antiviral properties, some antiretrovirals have an anti-NLRP3 inflammasome activity

Camille Vellas

Dysregulation of the colonic IDO-1/Kynurenine axis in PLWH: Links to dysbiosis and T cell exhaustion

For more information